Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Aurora Funds
AddedFeb 13, 2024
UpdatedJun 28, 2026
Aurora Funds

Aurora Funds

Operating

Aurora Funds, Inc.: A US-based venture capital firm investing in biotech, healthcare, and tech sectors.

Location
Cary, NC, US
Founded
1995
Firm
Compare
Portfolio
Employees
Website

Aurora Funds, Inc. is a US-based venture capital firm specializing in investments in biotechnology, healthcare, and technology sectors. The firm typically engages in Series A, B, and C funding rounds, with investment sizes varying across different stages. Aurora Funds focuses on high-growth potential companies in the medical devices, therapeutics, and healthcare services industries.

Notable portfolio companies include Metabolon, Blackboard, and CardioFocus, each having raised substantial funds. Key partners at Aurora Funds bring extensive industry experience and have been affiliated with prominent firms in the biotech and tech sectors. The firm emphasizes a hands-on investment philosophy, offering strategic guidance and operational support to its portfolio companies to drive growth and innovation.

Aurora Funds - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments31
Current Portfolio Count13
Total Portfolio Exits3

Top Investment Stages

Series B12 (41.4%)
Series A9 (31.0%)
Series C6 (20.7%)
Debt Financing1 (3.4%)
Series D1 (3.4%)

Stage Mix

Series B 41%Series A 31%Series C 21%Debt Financing 3%Series D 3%

Concentration shown as share of disclosed investments by stage.

Recent Investments

CardioFocus logo

CardioFocus

Metabolon logo

Metabolon

Centice logo

Centice

Altiris Therapeutics logo

Altiris Therapeutics

Recordant logo

Recordant

Cantex Pharmaceuticals logo

Cantex Pharmaceuticals

Visitar logo

Visitar

Cropsolution logo

Cropsolution

ALN Medical Management logo

ALN Medical Management

Neotropix logo

Neotropix

Widefi Networks logo

Widefi Networks

Psiloquest logo

Psiloquest

Stemco Biomedical logo

Stemco Biomedical

Norak Biosciences logo

Norak Biosciences

Zambeel logo

Zambeel

Alerts logo

Alerts

Engenia Software logo

Engenia Software

Blackboard logo

Blackboard

Technauts logo

Technauts

Aurora Funds - Similar Investment Firms

Aurum Partners logo

Aurum Partners

aurumpartners.vc

Aurora Capital Partners logo

Aurora Capital Partners

auroracap.com

Aurora Borealis Investments logo

Aurora Borealis Investments

Aphelion Capital logo

Aphelion Capital

Aurus logo

Aurus

aurus.cl

Aura Ventures logo

Aura Ventures

Visionary Venture Fund logo

Visionary Venture Fund

visionaryvc.com

Avoro Capital Advisors logo

Avoro Capital Advisors

avorocapital.com

Auriga Partners logo

Auriga Partners

aurigapartners.com

Avoro Ventures logo

Avoro Ventures

Avalon Ventures logo

Avalon Ventures

Energize Ventures logo

Energize Ventures

energizecap.com

Petrichor Healthcare Capital Management logo

Petrichor Healthcare Capital Management

petrichorcap.com

Tech Pioneers Fund logo

Tech Pioneers Fund

Boulder Ventures logo

Boulder Ventures

Aurora Funds - Classification

Also Known As
  • The Aurora Funds, Inc.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end